Understanding the Relationship Between BBBD Therapy and Maculopathy

December 3rd 2020, 4:00pm


Results of a retrospective case series revealed an association between blood-brain barrier disruption (BBBD)–related maculopathy and the number of BBBD treatment sessions patients underwent, suggesting a dose-dependent effect of the treatment.

Tool May Help Non-Ophthalmologists Triage Patients With Serious Ocular Injuries

December 1st 2020, 7:43pm


By analyzing retrospective consecutive case series, researchers identified 5 clinical and radiographic variables associated with increased risk of serious ocular injury in patients with orbital fracture to aid non-ophthalmologists in triaging these patients for urgent ophthalmologic evaluation.

Diffuse Macular Damage Linked to Diminished Facial Recognition, Contrast Sensitivity

November 27th 2020, 3:00pm


Among patients with glaucoma, diffuse rather than focal glaucomatous macular damage was associated with diminished facial recognition and contrast sensitivity, according to results of a cohort study published in JAMA Ophthalmology.

Visual Field Defects Are Consistent in Macular Measurements Among Those With Glaucoma, High Myopia

November 25th 2020, 3:30pm


Findings published in BMC Ophthalmology suggest that during diagnosis and follow-up of glaucoma with high myopia, more attention ought to be focused on structure and functional defects in macular areas.

Female Hormone Therapy Not Associated With Increased Risk of Retinal Vein, Artery Occlusions

November 18th 2020, 10:44pm


Women filling a prescription for female hormone therapy (FHT), and presumably taking FHT, are not at increased risk of retinal artery or retinal vein occlusions.

Meta-analysis Outlines Accuracy of Red Reflex Test

November 16th 2020, 5:30pm


An abnormal red reflex finding most likely reflects an underlying ocular pathology in infants, but finding a normal red reflex during screening does not altogether exclude ocular disease.

Rise in Drug Use–Related Hospitalizations for Endogenous Endophthalmitis

November 11th 2020, 4:38pm


Between 2003 and 2016, the United States saw a 4-fold increase in drug use–related endogenous endophthalmitis hospitalizations, contributing to a substantial health care use burden.

Research Highlights Efficacy of Teprotumumab for Thyroid Eye Disease

November 9th 2020, 6:32pm


New data to be presented at the American Academy of Ophthalmology’s Annual Meeting highlight the efficacy of Tepezza (teprotumumab), the first and only FDA approved medicine for thyroid eye disease.

Diabetic Retinopathy Severity Associated With Central Retinal Vessel Density in Eyes Without PPL

November 5th 2020, 5:30pm


Central retinal vessel density is associated with diabetic retinopathy severity in eyes without, but not with, predominantly peripheral lesions (PPL) according to a study published in JAMA Ophthalmology.

Vision Impairment Associated With Lower Preventive Screening Service Rates in Older Adults

November 3rd 2020, 8:15pm


Older Americans with vision impairment may be less likely to use cancer-related preventive services compared with their counterparts without vision impairment.